Skip to contentE
Eli Lilly & Co
E
LLYEli Lilly & Co LLY Q4 2010 · Eli Lilly & Co · ThalerSource filing unavailable
Q4 2010 · —
derived · Computed from the longer spans the company filed.
Revenue$6.19B$6.19Bderived+4.3% vs Q4 2009 No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Eli Lilly & Co · CIK 59478 · Engraved from SEC EDGAR
+9.4% vs Q3 2010
Net Income$1.17B$1.17Bderived+27.8% vs Q4 2009−10.2% vs Q3 2010 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Cash Flowderived$2,228,100,000+10.4% Margins · derivedNet margin18.9%+3.5 pt vs Q4 2009